Xiaoling Luo

机构：Sichuan University · ORCID：0000-0003-3301-8568

发表论文 58 篇 · 总被引 1242 次 · h-index 15

代表论文

• Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition (2022 · Annals of Translational Medicine · 被引 50)
• Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma (2024 · npj Precision Oncology · 被引 48)
• Advancements in programmed cell death research in antitumor therapy: a comprehensive overview (2024 · APOPTOSIS · 被引 22)
• Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer (2025 · Proceedings of the National Academy of Sciences · 被引 15)
• Epstein-Barr Virus Promotes Tumor Angiogenesis by Activating STIM1-Dependent Ca2+ Signaling in Nasopharyngeal Carcinoma (2021 · Pathogens · 被引 15)
• Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma (2024 · Pharmaceuticals · 被引 12)